Investor Presentaiton
Biotechnology | Scenario in India
India is among the top 12 biotech
destinations in the World
India is 3rd largest in terms of
biotechnology in Asia Pacific
India is the World's largest producer
of recombinant Hepatitis B vaccine
DESTINATION
UTTARAKHAND
UTTARAKHAND INVESTORS SUMMIT
DEHRADUN
EMERGING BIOTECHNOLOGY AREAS
उत्तराखण्ड शासन
Bio-similar
India holds 3% of the global market
share in Biotechnology
Bio-
Sensors
based
diagnostic
systems
Bio-fertilizers
&
Bio-pesticides
Synthetic
Biology
Bio-
Informatics
◉
By FY25, India's biotech Industry is estimated to increase to USD 100 billion from USD7 billion in
FY15
Biopharma is the largest sector contributing about 62% of the total revenue followed by Bio-services
(18%), Bio-Agri (15%), Bio-industry (4%), and Bio-informatics contributing (1%).
Fast-developing clinical capabilities with the country becoming a popular destination for clinical trials,
contract research and manufacturing activities
Uttarakhand Investor Handbook
Page 33View entire presentation